chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had skin cancer on her left cheek. It had been slowly growing for years and after the Covid vaccine it has resolved!; This is a spontaneous report from a contactable other healthcare professional. A 101-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection ;Lot Number: UNKNOWN), via an unspecified route of administration on Mar2021 as a single dose for covid-19 immunization at Nursing Home/Senior Living Facility. Medical history included Asthma, heart disease, skin cancer. It was unknown, whether the patient had allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient's concomitant medications were not reported. The patient had not received any other vaccine within four weeks prior to the COVID vaccine. The patient received unspecified chronic prescribed medications within 2 weeks of vaccination. It was unknown, the patient had any allergies. On an unspecified date in May2021, the patient experienced skin cancer on her left cheek. it had been slowly growing for years and after the covid vaccine it has resolved. The patient did not receive any treatment for the events. The Device Date was reported as 17May2021. The outcome of the event was recovered.  No follow-up attempts are needed; Information about Lot/Batch number cannot be requested.
On 1/22/2022 I woke up and I had little bumps all over my body. I thought it may of been bug bites or something since it was so long after the vaccine. The bumps turned into hives, I tried to use cortisone cream but it didn't help. I started taking Zyrtec, I was having to take it twice a day to keep the hives away, they lasted for about 1 week. I am still having to take the Zyrtec 1xday to keep the hives away, if I don't take it they come back. I went to the health clinic at my college and I was advised that I had dermatographia. I was just advised to keep taking the Zyrtec.
PT CAME WORKS IN THE STORE AND STOPPED BY TO TELL US HER ARM IS SO SORE SHE CAN NOT LIFT. IT STARTED 2-3 WEEKS AFTER SHOT AND IS GETTING WORSE. SHE SHOWED ME WHERE SHE GOT THE SHOT AND IT SEEMS FAR ENOUGH DOWN TO NOT CAUSE PROBLEMS IN THE SHOULDER. SHE IS GOING TO SEE THE DOCTOR AND LET US KNOW
This spontaneous report as received from a healthcare professional refers to a patient of unknown age. Medical history was not reported. The patient was vaccinated with the first, second and third dose of GARDASIL (routes, lot numbers and expiration dates not reported), on 16-FEB-2012, 07-DEC-2012 and 20-FEB-2013 respectively. No adverse effect was reported. Additional information has been requested.
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Severe, Systemic: Allergic: Rash Generalized-Severe
Fever/ fever persisted for 14 days now; Muscle pain; Joint pain; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jan2022 15:00 (Lot number: FL3209) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EJ1685, Location of injection: Arm Left), administration date: 28Dec2020, when the patient was 45 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3302, Location of injection: Arm Left), administration date: 14Jan2021, when the patient was 45 years old, for Covid-19 immunization. The following information was reported: PYREXIA (medically significant) with onset 09Jan2022 06:00, outcome "not recovered", described as "Fever/ fever persisted for 14 days now"; MYALGIA (non-serious) with onset 09Jan2022 06:00, outcome "recovered", described as "Muscle pain"; ARTHRALGIA (non-serious) with onset 09Jan2022 06:00, outcome "recovered", described as "Joint pain". The events "fever/ fever persisted for 14 days now", "muscle pain" and "joint pain" were evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (21Jan2022) negative, notes: Nasal swab. Therapeutic measures were taken as a result of pyrexia, myalgia, arthralgia.; Sender's Comments: The event of Pyrexia is assessed as possibly related to the suspect drug bnt162b2 based on temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
approx. 5-6 hours after vaccine:  rapid/racing/fluttering heartbeat, entire left side tingle sensation- restless ness
Fainting, rapid heart rate, pressure in head, seizures (non epileptic), chest pain and pressure, loss of speech and slurring speech, paralysis, weakness, numbness, tingling. I already called in the first time she was hospitalized and my report # is 543719. Hospitalized 5/22/21 thru 5/26/2021 and on 6/20/21 thru 6/22/21 with multiple Emergency Room visits in between hospital stays Diagnosed with Functional Neurological Disorder and Dysautonomia - POTS (Postural Orthostatic Tachycardia Syndrome which the doctor did say that the vaccine caused. She was a healthy 17 yr ols before she got the vaccine. She is treated with Propranolol 20 mg 2 times a day and takes 430 mg of Salt Caps 3 times a day.
Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 06Apr2021(at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included depression and anxiety. The patient had known allergy to Sulfa. The patient did not receive any other medication within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021(at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 the patient experienced fever of 100.4 (unspecified units) and chills and continue to have these symptoms till 14Apr2021. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 13Apr2021, the patient underwent rapid test (nasal swab) and the result was negative. The clinical outcome of the event fever and chills was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Given a dose reconstituted with a different diluent; Given a dose reconstituted with a different diluent; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Rota (Rotarix lyophilized formulation) for prophylaxis.   On an unknown date, the patient received Rotarix lyophilized formulation. On an unknown date, an unknown time after receiving Rotarix lyophilized formulation, the patient experienced inappropriate preparation of medication (Verbatim: Given a dose reconstituted with a different diluent) and inappropriate dose of vaccine administered (Verbatim: Given a dose reconstituted with a different diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 09-MAR-2023 The Clinic Manager reported that clinic had discovered they had a box of Rotarix containing 1 extra vial of lyophilized Rotarix powder, so they are unsure if a patient was possibly given a dose that was reconstituted with a different diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The Clinic Manager stated that they spoke to all of the staff that administered a dose from that box of vaccines, and all of the staff were able to verbalize the correct method for reconstitution, so they were unsure if any patient received an improperly reconstituted dose or not. The vaccine administration facility was the same as primary reporter. The reporter gave permission for follow-up and inadvertently did not obtain lot number. Case was conservatively kept valid for the inappropriate preparation of vaccine potentially administered to patient.
10-13-16 at 5:31 pm, spoke to mom via phone. Mom had just changed pt's diaper and saw small spots of blood in stool. No other symptoms. Possible reaction to rotovirus.
1. Muscle cramps/spasms in legs and feet 2. Unexplained bruising - about 6-8 episodes 3. Abdominal spasms - upper left side of stomach; feels like a ball rolling around or a baby kicking!
Swollen and painful lymph nodes under arms; Swollen and painful lymph nodes under arms; This is a spontaneous report from a contactable nurse (patient herself). A 40-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248; expiry date: unknown) via intramuscular route in the left arm, on 07Jan2021 at 14:00, at a single dose, for COVID-19 immunization. Relevant medical history included anxiety, depression, hypothyroid, and hypertension. The patient has no known allergies. Concomitant medications included levothyroxine, escitalopram, paracetamol (TYLENOL), ibuprofen, and marijuana. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ1685) intramuscular route in the left arm, on 18Dec2020 at 13:00, for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 08Jan2021, at 21:00, the patient experienced swollen and painful lymph nodes under arms. The patient did not receive treatment for the events. Outcome of the events was not recovered. The patient has not been tested for COVID-19 since vaccination.
I got COVID arm. My left arm was itchy and painful. There was a rash and swelling. The rash was not circular but it was noticeable. There was also a noticeable difference in temperature between the impacted area and the rest of my body. I felt fatigued on Sunday (4/25/21). I used an ice pack on it 3 times and yoga to stretch it out. The situation seems to be resolving on its own but there is still slight itching and slight swelling.
Tightness in the chest, throat, ears, and head with a feeling of dizziness started on the 4th day after receiving the vaccine. Feeling extremely fatigued and difficulty breathing. Falling asleep whenever and wherever. Rashes all over the body including the face that come and go. Burning pain and a feeling of flushing when the rash develops. Waking up in the nights with the rashes and itchiness that is unbearable. Experiencing difficulties staying focused and complete a single task. Off from work for a week now due to continuous dizziness.
1/6/2021 Hives, SOA, swelling, redness- Dx'd allergic reaction
Dose 2-7/13/2021, Dose 3-8/12/2021; second dose of 11 days apart; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a male patient who received HBV (Engerix B adult) (batch number 74EM4, expiry date 20th December 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B adult) for prophylaxis and hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included HEPATITIS B VACCINE (ENGERIX B ADULT).   On 13th July 2021, the patient received the 2nd dose of Engerix B adult (intramuscular) 1 ml and Engerix B Pre-Filled Syringe Device. On 12th August 2021, the patient received the 3rd dose of Engerix B adult and Engerix B Pre-Filled Syringe Device. On 13th July 2021, unknown after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device, not applicable after receiving Engerix B adult and Engerix B Pre-Filled Syringe Device and an unknown time after receiving ENGERIX B ADULT, the patient experienced drug dose administration interval too short. On 12th August 2021, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short and drug dose administration interval too short were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd and 3rd dose early than the recommended time interval, which led to shortening of vaccination schedule. The reporter ststed that, the patient received 2nd dose 11 days apart, instead of 4 weeks apart. The reporter gave a consent to follow-up with herself.
the patient was supposed to receive  the first dose of the  Moderna primary series, but instead received the Moderna Update Booster for age 6+ as the first dose. Patient's Dad said that patient did not experience any adverse side effects.
12/9 - 9am booster shot  12/9 - 10pm-1am violent shaking and chills  12/10 - 1am - 3am, high fever, muscles ache, fatigue, muscle control loss, shortness of breathe 12/10 - woke up tired, achy, some nausea, couldn't walk up stairs, hard to breathe. Symptoms continued throughout the day.  12/11 - Woke up tired, achy felt better throughout the day.  12/12 - Woke up feeling decent, joint pain, muscle fatigue. Nausea, vomiting and diarrhea developed into late morning, severe leg pain got worse starting at noon. 12/13 - Nausea, vomiting and diarrhea worsened, wasn't able to eat or drink anything for the day.  Went to clinic for COVID test, RAPID came back negative. Two other members of my household also tested negative.  12/14 - Vomiting subsided, nausea and diarrhea continued. Contacted my doctor, suggested I take an anti-diarrhea over the counter medicine and keep trying to drink fluids. At home COVID test was negative.  12/15 -  Nausea and diarrhea improved, fatigue and body aches still present. At home COVID test was negative.  12/16- Symptoms mostly subsided, took another COVID test that was again negative. PCR Test came back negative.
States started with side effects that evening around 6pm. Symptoms include fatigue, nausea, tiredness, body aches, feeling unwell. Calling for follow-up because it has been over 48 hours since the vaccine and she still has symptoms. Now having sinus pain and congestion. Advised to follow-up with PCP. Placed order for COVID. COVID test on 1/19/21 resulted negative.
This spontaneous report was received from a physician and refers to multiple unspecified patient of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (exact dose and route of administration were not reported, lot # L023232 with expiration date: 25-FEB-2017). The administered doses experienced a temperature excursion of 30 degrees Fahrenheit for 7 hours. No previous temperature excursion was reported. No adverse effect was reported. This is one of two reports received from the same reporter. Additional information has been requested.
Patient presented to our emergency department on 6/28/21 with neutropenic fever.  Patient has a history of multiple myeloma.  Patient's COVID test resulted positive, patient is fully vaccinated.  Patient received steroids for his neutropenia.  Patient also received antibiotics, oxygen, casirivimab/imdevimab and remdesivir.  Patient recovered and was discharged to home.
Started to itch at the site around 5pm the day of the injection.  The site was red and swollen mid bicep on 9/20/19 slightly warm to touch.  Called doctor's office and they told patient to take benadryl, & use cold compress for 15 to 30 minutes every 1 to 2 hours.
I want to report that the side effects I suffered with the Shringrix vaccine were worse than the drug info provided online led me to believe.  I was incapacitated for 24 hrs with both doses.  Site soreness, though present, doesn't need to be discussed. But a fever of 100F, body wracking shivers, myalgia, joint pain, difficulty walking a straight line, feeling like my skin was tingling and painful, a severe headache, and violent vomiting were horrible with the 1st vaccine.  I was surprised that as bad as it was, the second was worse.  Everytime I took motrin, it was back up in 5 minutes.  I expressed understanding to my husband at how people with chronic pain could be driven to suicide.  Ifelt that bad.. .and paniky, anxious, desperate. Luckily, I understood and believed what I was experiencing would be temporary.  If there were a third dose in the series, I wouldn't take it.   I am writing to say, patients should be better informed and approached with more honesty.  The CDC has a poor reputation for truth telling among the public.  At least advise people not to get the vaccine prior to a workday.
Difficulty breathing; Body pain; Fever of 101; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), MYALGIA (Body pain), PYREXIA (Fever of 101) and HEADACHE (Headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Bronchitis. Concomitant products included ALBUTEROL [SALBUTAMOL] for Asthma.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. In April 2021, the patient experienced DYSPNOEA (Difficulty breathing), MYALGIA (Body pain), PYREXIA (Fever of 101) and HEADACHE (Headache). At the time of the report, DYSPNOEA (Difficulty breathing) had not resolved and MYALGIA (Body pain), PYREXIA (Fever of 101) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Body temperature: 101 (High) 101.         No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable
Moderna 8/27/21, 9/24/21, 5/24/22. Positive on 5/27/22
sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In June 2022, the patient received Shingles vaccine. In June 2022, less than 2 weeks after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was not recovered/not resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     Additional Information: GSK receipt date: 16-June-2022 Reporter's comment: The patient self-reported the case via interactive digital media. The patient had vaccine last week and felt sick at the time of reporting.
PT is 20 YO male, here for first dose of Moderna, received at 1610. At approximately 1620, PT was in post vaccination area and c/o of faintness, weakness, that he couldn?t hear, was ?disoriented?, had ringing in ears. ?Felt like I was dying.? No LOC noted. Warm, slightly diaphoretic, clammy, presented with pallor. Declined wheelchair, moving to stretcher, or putting head between knees despite encouragement. Given apple juice and apple slices, small granola bar; well tolerated along with water bottle. States ?haven?t had much to eat today.? Pale in color at onset, resolved with more color at discharge. Stated faintness was improving. PT was able to stand and walk without assistance. PT was talking more, stated he was feeling better, was more responsive. DC/d with steady gait, able to clothe self, finish snacks. States no allergies, has passed out in shower after taking herbal supplements in the past. Education regarding vasovagal reactions provided.  PT was encouraged to eat more before 2nd dose, advised to be hydrated and to tell vax team of previous issues when he comes for second dose. Exited at 1440 with friend, who will drive.  Vital Signs: 1620: BP 90/50 sitting, HR 49, SPO2 100% RA, RR 12 1625: BP Sitting 110/60, HR 57, SPO2% RA, RR 14 1629: HR 65, SPO2 100% RA, RR 14 1637: BP 110/62 sitting, HR 52, SPO2 100%, RR 16
I experienced feverish, nausea, achiness in my head ached, I was very ill, few hours after my vaccine. I felt very weak and achy, slept a lot. The thing that frightened me the most was the fever. I took an anti nausea medication for relief of nausea. I do not have any symptoms today.
low grade fever, vomiting, dehydration; immun given 12MAR93-admitted to hosp 21MAR93 AM w/dehydration;
pt recvd vax 11SEP92 & on 15SEP92 devel raised rash on the front of trunk; rash spontaneously resolved w/in 24 hrs; No further details were provided;
2-3" area of erythema with swelling to R thigh-probably DTaP site.
Dose 3/Booster?..side effects were severe chills, aches, nausea, headaches?.much like a severe, common flu.
Left arm was sore; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 27Apr2021 at 15:30(at the age of 48-year-old) as a single dose for COVID-19immunisation. Medical history included asthma, obesity, anemia, autoimmune disorder, ehlers-danlos syndrome, POTTS .The patient previously took amoxicillin (MANUFACTURER UNKNOWN) ,codeine (MANUFACTURER UNKNOWN), topamax (MANUFACTURER UNKNOWN), agave syrup (MANUFACTURER UNKNOWN) and experienced drug allergy for the following medications . Concomitant medications included phentermine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date, excedrin (MANUFACTURER UNKNOWN) for migraine on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19 . The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 19:00 the patient experienced left arm sore. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left arm sore was recovered after 3 days of vaccine.   No follow-up attempts are needed. No further information is expected.
6-12 hours post injection L arm pain at site up through neck, tender to touch.  Double vision in left eye. 6th cranial nerve palsy.